SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " pivot " 533 found 🔀 AI-powered Shuffle
Rays Roundtable: Yankees Showdown, Playoff Rotation and October Concerns
The Tampa Bay Rays enter their final seven AL East games with a five-game lead over the Yankees. Our Rays Roundtable discusses the pivotal series in New York, Kevin Cash's postseason rotation, bullpen concerns and what Tampa Bay needs to do before the MLB playoffs.
Eye of the Tiger: Pivotal position matchups vs. Ole Miss
Which specific matchups could be key on Saturday night?
Melinda French Gates Shares the State of Women’s Health
Melinda French Gates joins the 3rd Hour of TODAY to talk about new surveys from her organization, Pivotal, which found that one in four women are living in fair or poor health. “Women have been telling us this for years, and yet we’re not making changes to really support them in their health,” she says, adding, "I want to make sure that women can get the care they deserve at the right time in life." Melinda also talks about doubling donations at Olivia Rodrigo’s Daisy Chain Fields Festival and opens up about being a grandmother. "They are just the light of my life," she says of her two grandchildren.
Q&A: Dakotah Tyler on fashioning a science communication business
After an injury forced him to pivot away from football, Tyler had a chance encounter that ignited his curiosity about exoplanets.
Q&A: Dakotah Tyler on fashioning a science communication business
After an injury forced him to pivot away from football, Tyler had a chance encounter that ignited his curiosity about exoplanets.
The king and AI: UK monarch Charles meets artificial intelligence leaders as safety concerns swirl
LONDON (AP) — King Charles III on Thursday urged senior leaders from OpenAI, Anthropic, Google DeepMind and Nvidia to make sure that artificial intelligence remains under control and in the service of people and the planet. The gathering in Scotland was convened to discuss how AI can benefit society, and comes at a pivotal moment […]
North Carolina Suspends Wide Receiver Right Before Clemson Game
Freshman Keeyun Chapman faces indefinite suspension following a weapons charge, adding to the off-field turmoil surrounding Bill Belichick’s program just days before a pivotal showdown against Clemson.
High school science teacher discovers rare T. Rex tracks: 'A real pivotal moment'
Kent Hups could not contain his excitement when he came across several giant three-toed track prints that appeared to be T. Rex footprints in North Dakota.
High school science teacher discovers rare T. Rex tracks: 'A real pivotal moment'
Four footprints were found in a sequenced trackway.
Veteran Linked To Miami Heat Joins Eastern Conference Contender
After John Konchar snubbed the Miami Heat for the reigning champion New York Knicks, the team must pivot to remaining free agents to finalize their star-studded, championship-caliber rotation for next season.
Congressional Black Caucus Foundation marks 50 years at pivotal time
The CBC Foundation's annual conference will kick off in Washington to discuss the priorities of Black life in America.
Senate blocks crypto regulation as Democrats push back on Trump investments
The 49-50 vote on whether to move forward with the legislation was a pivotal election-year test for the $2.3 trillion cryptocurrency market
Senate is to vote on cryptocurrency regulation as Democrats push back on Trump investments
WASHINGTON (AP) — The Senate is set to vote Tuesday on whether to move forward with legislation to create a new regulatory framework for cryptocurrency, a pivotal election-year test for the $2.3 trillion market as many Democrats say it doesn’t go far enough to rein in President Donald Trump’s investments. The vote, just two months […]
Guard Linked To Miami Heat Joins Eastern Conference Rival
After missing out on Devin Carter to the Boston Celtics, Miami must pivot to finalize their roster. The legacy prospect's move forces Pat Riley to reconsider remaining free-agent targets.
Paramount's possible Hollywood exit puts Los Angeles on edge
LOS ANGELES — Paramount Skydance Chief Executive David Ellison faces a pivotal decision: Should he uproot his Hollywood studio — the birthplace of such film classics as "Sunset Boulevard," "The
Puget Sound business leaders warn of Washington's slipping economy
Some of the largest employers in Washington say the warning signs of an economic decline are clear, and are now urging city and county leaders to pivot quickly.
Jalen Hurts narrates Ryan Clark’s next chapter after ESPN departure
Jalen Hurts and Odell Beckham Jr. helped narrate Ryan Clark’s announcement launching The Pivot Sports following his ESPN departure
Former Miami Heat All-Star Praises Davion Mitchell's Work Ethic
Norman Powell hails the defensive specialist’s relentless gym habits as the guard gears up for a pivotal contract year alongside the Miami Heat's newly formed superstar core.
Apple May Pivot the Beats Brand Into a Way of Marketing Less Polished Products, Starting With Gamer Gear
Bloomberg's Mark Gurman claims that the "culture and lifestyle around gaming controllers" makes sense for Beats.
Saints at Lions live updates: Score, highlights, predictions, analysis
The New Orleans Saints visit the Detroit Lions in a pivotal Week 1 showdown. Follow live score updates, highlights, injury news, and instant analysis.
Nets Labeled as ‘Noncompetitive Without Own Pick’ in 2025-26
With Houston controlling their draft fate, Brooklyn pivots toward a veteran-led push for the Play-In, betting on Julius Randle and new depth to defy low expectations.
Eye of the Tiger: Pivotal position matchups vs LA Tech
Which specific matchups could be key on Saturday night?
Live updates: Michigan football faces Oklahoma in pivotal game
Michigan football seeks redemption against Oklahoma in a high stakes matchup with playoff implications on the line.
Exclusive: Joe Morton On Star Trek, A Life In Science Fiction, And His Pivotal ‘Terminator’ Role
Science fiction legend Joe Morton has just joined Star Trek. Here's what he says about his new episode and his time with Skynet in 'Terminator 2.'
Titans Make Roster Addition Ahead of Sunday's Game vs. Jets
Tennessee signs cornerback Jaylon Jones to the active roster, reuniting the former Colts starter with defensive coordinator Gus Bradley just days before a pivotal matchup against New York.
Content creator Cameron Parker talks community, consistency and career pivots with RCOB students - Gary W. Rollins College of Business
Content creator Cameron Parker spoke to Professor Ryan Russell's Social Media class at UTC's Gary W. Rollins College of Business about authenticity, consistency and turning content into a career.
Nebraska's Online Sports Betting Ballot Campaign Pivots to General Election
Major sportsbooks spent more than $7 million on the signature drive as Nebraska online sports betting proponents prepare for a Nov. 3 statewide vote.
Supreme Court again rejects push to use Trump-backed congressional map in Missouri
The U.S. Supreme Court again rejected Missouri congressional maps backed by President Donald Trump on Thursday, a loss for Republicans trying to maintain control of the House in the pivotal midterm elections.
WATCH: Trump says oil prices will come down after midterm elections
President Donald Trump, in an exchange with reporters before traveling to Dallas for the midterm Republican convention, added that he believes Iran will finally relent after the pivotal elections are held in the U.S.
Ballots discounted for late postmarks surged in Washington and Oregon after Postal Service changes
The number of ballots rejected for late postmarks has soared in the vote-by-mail states of Washington and Oregon, according to newly released data highlighting concerns about recent changes in U.S. Postal Service operations ahead of this fall's pivotal midterm election.
Michigan Justice Fund pivots to national stage with New York fiscal sponsor
The organization helped spur the state to redirect $200 million from incarceration and achieve the state’s lowest imprisonment rate in three decades.
The 98 Biggest TV Show Flops, Bombs and Misses in the First Half of 2026
(Welcome to the Entertainment Strategy Guy, a newsletter on the entertainment industry and business strategy. I write a weekly Streaming Ratings Report and a bi-weekly strategy column, along with occasional deep dives into other topics, like today’s article. Please subscribe.) In July, I updated my look at how the “streaming bubble” popped since 2023, showing the decline in streaming TV shows over time. But after compiling and analyzing and writing about over one hundred TV show flops in the first half of 2026—I counted 99 “nominees” and there are even more honorable mentions—I couldn’t have told you that the number of shows is going down. When it comes to scripted, English-language TV shows, it feels like we have as many bombs as ever. I don’t keep a specific count, but some streamers probably had as many flops as they’ve ever had.1 That’s right, it’s time for part two of my analysis of the biggest flops, bombs and misses on streaming in the first half of 2026. Two weeks ago, I took a look at films. Today, TV shows. If you want to read the full methodology for how I assemble this list, you can find it at the bottom of this article. In short, this list is… ...scripted and unscripted TV shows,...from the nine major streamers,...in the US (using US-only ratings),...excluding true crime, kids and foreign-language shows,...that got no/poor ratings,...from Jan-2026 to the end of June-2026. Reminder: this article does not represent my personal opinion—many of these shows are great!—but I follow the data, and a miss is a miss and a bomb is a bomb. Also, price matters. If a TV show costs north of $100 million, it needs to get lots and lots of streaming viewership to justify that budget. As with past editions, I ordered this list by streamer, going from best (fewest flops) to worst (the most misses)—taking the size of the flops into consideration—and like the last edition, three or four streamers vied to take the win/loss of having the most flops. (But the actual winner is no surprise.) I try to avoid tooting my own horn too much, but seriously, in just under 5,000 words (including the methodology section) I provide a mostly comprehensive overview of the eight major streamers (Netflix, Disney+, Prime Video, Hulu, HBO Max, Peacock, Paramount+, and Apple TV) for the first half of the year, mentioning most of their hits and all their misses. It summarizes the entire first half of 2026! If you want to support this work, please subscribe. Subscribe Tubi Big Mood Boarders The Freak Brothers Twenty Twenty Six Honorable Mentions: Busted on Bodycam, Deestroying the Pitch, Destination World Cup 2026 I don’t think that Tubi spends all that much making or (mostly) licensing these original TV shows—Big Mood, Boarders and Twenty Twenty Six all come from the UK—but they’re not free and they didn’t chart anywhere. Winner: The Freak Brothers Have you even heard of this show? It’s an animated comedy...that’s on its third season! And Pete Davidson, Woody Harrelson, John Goodman and Tiffany Haddish all provide voice talent for it. Yes, animated shows don’t cost as much as live action shows, but cheap isn’t free! So a show with this level of talent needs to perform better. Disney+ Daredevil: Born Again Star Wars: Maul – Shadow Lord Honorable Mentions: Behind the Attraction, Donna Hay Coastal Celebrations, We Call It Imagineering Disney+ doesn’t make all that many original shows anymore. They had two flops, and one was animated. Their one not-a-miss show, Wonder Man, got just good enough viewership to not be considered a “miss”...but it’s since been cancelled. At this point, Disney has pivoted entirely away from making big budget TV shows for Disney+ to making...almost nothing for Disney+? Sure, Disney’s spending circa 2019-2022 was unsustainable, but now they’re pivoting too far in the other direction. At some point, Disney needs to stop shifting strategies so wildly. Really, Disney should have made fewer shows for Disney+ at launch and the shows they did make at that time needed to be made at more reasonable budgets. And they should adopt that strategy now. Winner: Daredevil: Born Again Daredevil, the Marvel Comics character, is on my personal Mount Rushmore of favorite superheroes, so it pains me to give him the win/loss today, but this show deserves it. I’ll repeat my hot take from last spring: “Based on his popularity, Daredevil should be in movies, and probably ones that cost a lot less than the MCU’s usual price tag. Disney/Bob Iger/Ike Perlmutter (who, based on reporting, made the decision) made a huge mistake selling TV shows to Netflix in the 2010s, thus limiting this character to the small screen. Daredevil could have anchored Marvel’s post-Infinity War plans, and if he did, the MCU would probably be in a better place than it is now.” HBO Max We’re just getting started with this issue, but the rest is for paid subscribers of the Entertainment Strategy Guy, so if you’d like to find out… What four streamers had the most misses... HBO’s strong start to 2026… The caveat to Peacock’s turnaround this year... Paramount+’s key man problem… What country isn’t delivering hits for Netflix or Hulu... The cavalcade of stars on a streamer where no one is watching their shows... Across nearly 5,000 words of analysis… And a lot more... ...please subscribe! We can only keep doing this great work with your support. If you’d like to read more about why you should subscribe, please read this article about the Streaming Ratings Report, why it matters, why you need it, and why we cover streaming ratings best.
Three Marginal Trends For Orlando Magic Offseason
Navigating tight financial constraints, Orlando pivots toward low-risk gambles like Malaki Branham to bolster Paolo Banchero’s core while testing the limits of their high-apron roster flexibility.
Solomon Islands domestic political squabbles could frustrate diplomatic engagement
No confidence motion withdrawn, but experts say volatility could undermine PM Wale’s pivot to Canberra, Washington
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.
Did Marks Save Nets Future With Rockets Trade in 2024?
By reclaiming pivotal draft assets from Houston, Brooklyn secured the building blocks of a new era, pairing Egor Dëmin with Mikel Brown Jr. to anchor a revitalized backcourt.
Science Spotlight: AI could be 'pivotal' in eco-innovation for beauty
Artificial Intelligence (AI) technologies can help beauty companies accelerate eco-innovation from start to finish, aligning efforts to key United Nation sustainability goals. According to a review published in Cleaner Production Letters, however, use of AI to drive sustainable cosmetic innovation remains underexplored. Up until now, the integration of AI into the cosmetics industry has “predominantly focused on personalisation, marketing, and supply chain optimisation,” the researchers...
Third time the charm? Democrat Christina Bohannan tries again in pivotal US House race in Iowa
Democrat Christina Bohannan is making a third attempt to win a congressional seat in Iowa's 1st District. She lost to Republican Rep. Mariannette Miller-Meeks in 2022 and 2024.
Chicago Cubs Announce Starting Pitchers for Pivotal Series Against Brewers
The Chicago Cubs are coming off a 10-3 loss to the Miami Marlins on Sunday, but they still won two of three games in the series.They’ll have to turn the page quickly, though, as they prepare to take on the Milwaukee Brewers on Monday afternoon in a pivotal NL Central series.The Cubs still trail the […] The post Chicago Cubs Announce Starting Pitchers for Pivotal Series Against Brewers appeared first on HEAVY.
Toronto Blue Jays Announce Trey Yesavage Update Amid Playoff Push
The Toronto Blue Jays welcomed back Jameson Taillon from the IL on Friday night against the Kansas City Royals, but they’re still awaiting the potential return of Trey Yesavage.Yesavage played a pivotal role as a rookie last year during the Blue Jays’ World Series run, and before his injury this season, he quickly became Toronto’s […] The post Toronto Blue Jays Announce Trey Yesavage Update Amid Playoff Push appeared first on HEAVY.
Maria Bartiromo vs. Fox News: Pivot Between Politics, Wall Street Hurt
Maria Bartiromo's ongoing pivot between politics and coverage of Wall Street likely hurt her standing at Fox News
Maria Bartiromo vs. Fox News: Pivot Between Politics, Wall Street Hurt
Maria Bartiromo's ongoing pivot between politics and coverage of Wall Street likely hurt her standing at Fox News
Three Crucial Storylines for Orlando Magic this Season
Paolo Banchero’s quest for durable superstardom and Franz Wagner’s pivotal summer of recovery define a high-stakes season as Orlando’s core prepares for a grueling 82-game grind.
Eye of the Tiger: Pivotal position matchups vs Clemson
Which specific matchups could be key on Saturday night?
One year after its founder's death, Armani faces challenge of 'inevitable evolution'
One year after the death of founder Giorgio Armani, the Italian fashion house is entering a pivotal period as the clock starts ticking on plans for an initial stake sale, after the group spent the last year focused on governance.
Judge makes pivotal ruling in favor of former NFL players attempting to return to college football
A federal judge has granted an injunction that could reshape the LSU Tigers’ roster and college football eligibility, paving the way for more than 40 athletes, including potential LSU transfers Dae’Quan Wright and Zxavian Harris, to return to the college…
Antarctic expedition reveals why Southern Ocean clouds remain one of climate science's greatest challenges
The Southern Ocean plays a pivotal role in regulating Earth's climate, yet the clouds that blanket this remote region remain among the least understood features in atmospheric science. By controlling ...
Coffee brand gets a head start: How UTC's Veterans Entrepreneurship Program helped one veteran take the next steps - Gary W. Rollins College of Business
Veterans Entrepreneurship Program helped Durand Henderson pivot from military service to startup coffee roaster.
‘Atlanta is Deion’s city’: Deion Sanders begins pivotal Colorado season in city where star was born
In the early 1990s, Deion Sanders was Atlanta's two-sport athlete, starring for the Falcons and playing in the World Series with the Braves.
Israel’s politics pivot to shared good health
A prominent Zionist politician will run in the next election with an Israeli Arab party, perhaps making it a political kingmaker. His vision: an Israel that can heal its many divides in a way similar to how institutions of healing provide universal care based on equal dignity.
Minnesota Vikings Silence Noise After Big Announcement
With J.J. McCarthy sidelined by injury, Kyler Murray takes the reins as QB1 while veteran Carson Wentz solidifies the depth chart ahead of a pivotal Week 1.
AfterQuery Becomes YC’s Fastest Unicorn At $3.2 Billion
Twenty three year-old Spencer Mateega pivoted his YC startup into the fastest unicorn in the accelerator’s history, fueling AI's shift toward human reasoning data.
Oregon Ducks Receive Promising Update on 2028 QB Prospect
Rising high school star Tommy Devany eyes a high-stakes visit to Eugene as Dan Lanning pivots his powerhouse recruiting strategy toward a new generation of elite quarterbacks.
Postdocs Share Advice for Navigating Early-Career Science
From finding the right mentor to setting boundaries, postdoctoral researchers offer advice for navigating this pivotal stage.
Minnesota company is tackling nitrogen pollution with ag science in volatile fertilizer market
Pivot Bio, a company selling farmers a self-sustaining, non-synthetic, bacterial source of nitrogen, aims to lower the nitrogen levels that are the source of significant water pollution in farm states.
Weekend series marks reminder of Red Sox-Yankees playoff inevitably
Take this weekend to get ready, because I would be SHOCKED if the American League playoffs don’t open on Sep. 29 with the Red Sox and Yankees matched up in the Wild Card series. Boston and New York square off for the final time this (regular) season this weekend at Yankee Stadium in a pivotal […]
Health may finally allow Nolan Smith to answer lingering questions
After three seasons of flashes, injuries and unanswered questions, Nolan Smith enters a pivotal contract year hoping to prove he's a cornerstone.
Third time the charm? Democrat Christina Bohannan tries again in pivotal House race in Iowa
Bohannan is focusing on rural areas she previously lost, hoping to capitalize on Trump's declining popularity and economic issues.
Data centers are ‘redefining’ midterm races across Pennsylvania
Candidates in at least 20 competitive legislative races are staking out data center positions, and Gov. Josh Shapiro has pivoted to a tougher stance.
Third time the charm? Democrat Christina Bohannan tries again in pivotal US House race in Iowa
Democrat Christina Bohannan is making a third attempt to win a congressional seat in Iowa's 1st District.
NASA’s nuclear Dragonfly copter to search for signs of life on Titan: 'A lot's riding on it'
As the agency pivots to putting astronauts on the moon, this $3-billion space-copter is the agency’s last large-scale mission to explore the solar system.
The Patriots have found their commander in the secondary
Second-year pro Craig Woodson will play a pivotal role for the Patriots in 2026.
Data center politics take over PA midterms
Candidates in at least 20 competitive legislative races are staking out data center positions, and PA Gov. Josh Shapiro has pivoted to a tougher stance.
Kevin O’Connell Reveals Randy Moss’s New Role With Vikings
The Minnesota Vikings are leaning on all-time great wide receiver Randy Moss as the team enters a pivotal season. The post Kevin O’Connell Reveals Randy Moss’s New Role With Vikings appeared first on HEAVY.
‘Doesn’t wanna win’: Charlamagne Tha God bashes Hakeem Jeffries over healthcare
if a political leader as powerful as Hakeem Jeffries changes position on a major issue, voters deserve more than a pivot. They deserve the why and, more importantly, the what now.
4 Tests To Pass Before You Take Your Side Hustle Full-Time
Wondering when to turn your side hustle into a full-time business? Use four tests to assess demand, economics, career fit and your readiness to pivot.
Dodgers news: Dave Roberts provides pivotal Edwin Diaz injury update
Los Angeles Dodgers closer Edwin Diaz was placed on the injured list due to neck inflammation on Tuesday. Dodgers manager Dave Roberts told reporters the team would know more about the situation on Wednesday, but he did say that he expected Diaz to return this season . Sure enough, the update on Wednesday does indeed hint at Diaz avoiding a […] The post Dodgers news: Dave Roberts provides pivotal Edwin Diaz injury update appeared first on ClutchPoints.
‘We cannot send this item’: Ontario business pivots as Canada-U.S. tariff deadline looms
As trade talks continue between the U.S. and Canada, businesses on both sides of the border are bracing for potential fallout from a looming tariff deadline. That negotiation deadline between the U.S. and Canada is Wednesday.
Live Results: Alaska midterm primaries
Alaska voters will narrow down a long list of contenders Tuesday for a competitive U.S. Senate seat that’s expected to play a pivotal role in determining which party will hold a majority in the chamber next year.
BIG PIVOTS: The Nexus of Climate Change Politics in Colorado
Our Colorado mountain town is being hammered by climate change. We are responding in many ways…
As Asian business ownership declines, Tulsa commissioners pivot focus
The percentage of Asian Tulsans who own businesses is dropping. Asian Affairs commissioners are responding, shifting their focus from events to business resources.
St. Louis Cardinals vs Cincinnati Reds Series Preview
The St. Louis Cardinals begin a brutal week where they’ll play 5 games in 4 days against the Cincinnati Reds beginning with a day/night doubleheader on Monday. What we know about pitching matchups already shows this might be one of the most interesting and possibly pivotal weeks of the season so far. Here are the […]
Big Pivots: Ambition, affordability and the nexus of climate change politics
In Crested Butte, Republican voter registration barely breaks 5%. Given this political makeup, Crested Butte might seem like a strange venue for dissecting American polarization over climate change. The national pace of climate action, however,...
Big Manufacturers Find New Demand in Equipping AI Data Centers
Companies such as Caterpillar and Cummins are pivoting to feed a booming market for once-prosaic machinery.
Irving: Buccaneers QB Mayfield Brings Energy to Every Huddle
Starting quarterback Baker Mayfield is entering a pivotal contract season, but with training camp underway, extension talks have ceased. See what Bucky Irving had to say about his QB and what he brings to the team.
FDA approves pivotal trial for FastWave Medical's peripheral IVL system
The SPARC trial will enroll up to 125 patients with peripheral artery disease.
Dodgers news: Blake Treinen shares pivotal injury update
Dodgers reliever Blake Treinen talked to reporters after his live session, where he expressed his optimism about his return
Space tech: an orbiting market opportunity | Investors Lab
While AI models are excellent at parsing massive amounts of data, they struggle to pivot when faced with unprecedented events — the kind that frequently occur in the vacuum of outer space. Space operations are a zero-tolerance environment where the cost of a software miscalculation can be a total loss of assets or human lives. The solution isn't to abandon the technology, but to pivot toward human-assisted systems where an AI algorithm handles the heavy computational lifting while human experts serve as guides on the ground and remain the ultimate decision makers in aerospace technology. SN's Aaron Tremper takes us there.
Alexandria Ocasio-Cortez’s pivot on ‘woke’ politics isn’t unreasonable
What Ocasio-Cortez’s viral ‘woke one was crazy’ remarks reveal about how the left is evolving.
Rebecca Cooke Wins Democratic Primary for Key Wisconsin House Seat
Ms. Cooke, a three-time congressional candidate, held a huge fund-raising edge in a western Wisconsin race that Democrats consider pivotal to their hopes of flipping the House.
Trump Media posts massive $238M loss, plans major business pivot
Trump Media & Technology, the company owned by President Donald Trump, posted a $238 million loss over the past three months, prompting the business to pivot to a new focus on users' social media use.
Trump Media posts massive $238M loss, plans major business pivot
Trump Media & Technology, the company owned by President Donald Trump, posted a $238 million loss over the past three months, prompting the business to pivot to a new focus on users' social media use.
Science backs calls for limiting screens in schools
School device use links with lower test scores and distractions abound. But reversing the entrenched pandemic pivot to screens will be hard.
AbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on notice
AbCellera has reported phase 2 results “beyond even the most aggressive upside scenario” that its CEO dared to consider, boosting the biotech’s chances of challenging Astellas and Bayer for a women’s health market. The phase 2 clinical trial compared ABCL635, an antibody targeting NK3R, to placebo in patients with hot flashes caused by menopause. Investigators enrolled 92 postmenopausal women experiencing a mean of about 10 moderate or severe hot flashes per day. By Week 4, the number of moderate or severe hot flashes had fallen by a mean of 8.8 on ABCL635 and by 3.5 on placebo. That statistically significant, placebo-adjusted reduction of 5.3 hit the trial’s primary endpoint. The level of efficacy also cleared the bar set by existing drugs. While cross-trial comparisons can be misleading, AbCellera CEO Carl Hansen, Ph.D., had seen enough to start hyping the program. “We now view ABCL635 as a potential best-in-class non-hormonal therapy with strong differentiation against approved NK3R competitors across all important dimensions, including efficacy, safety, dosing and convenience,” Hansen said on a Monday morning conference call with investors to discuss the data. “We believe ABCL635 is now a highly de-risked program.” Last week, Hansen used AbCellera’s earnings call to set expectations for readout, with the CEO defining success as a clean safety profile and efficacy comparable to the two approved small molecules. The data vaulted over that bar. Astellas linked (PDF) one of the small molecules, Veozah, to placebo-adjusted reductions in hot flash frequency of 2.1 and 2.6 at Week 4 of its two phase 3 trials. Bayer reported (PDF) placebo-adjusted reductions of 3.04 and 3.29 at Week 4 of pivotal studies for its small molecule, Lynkuet. At 5.3, the placebo-adjusted reduction in AbCellera’s trial comfortably cleared the standard set by the incumbents. Veozah and Lynkuet came to market based on evidence of their ability to reduce the frequency and severity of hot flashes. AbCellera’s phase 2 study covered both endpoints, with the Canadian biotech reporting a mean reduction in severity of 1.4 points at Week 4 on ABCL635, compared to 0.3 points for placebo. Again, the placebo-adjusted result compares favorably to data on Veozah and Lynkuet. Analysts shared Hansen’s enthusiasm for the data. The phase 2 results “firmly validate ABCL635 as a potentially best-in-class treatment,” BMO Capital Markets analysts said in a note to investors Monday. ABCL635’s apparent efficacy edge “is likely attributable to the higher dosing/target engagement the asset is able to reach vs. the oral agents due to its wider therapeutic index,” the analysts added. The analysts, who model $2.3 billion in unadjusted peak sales for ABCL635, flagged the safety profile as another positive of the phase 2 readout. While Veozah carries a boxed warning for liver damage, nobody on ABCL635 in the phase 2 trial had elevated liver enzymes or bilirubin values. If replicated in phase 3, the lack of a liver signal could allow approval without the monitoring requirements imposed on Veozah. Investors appeared equally enthused, sending AbCellera's stock up 32% to $9.21 in premarket trading Monday from a Friday closing price of $6.93. Next, AbCellera will collect the Week 12 data and talk to its advisors about further development. The results open up “a wide variety of possibilities of how we might take this forward into phase 3 studies to truly maximize the value of the asset and make sure that ABCL635 is able to demonstrate its differentiation potential,” Sarah Noonberg, M.D., Ph.D., AbCellera’s chief medical officer, told investors.
Square Enix Reportedly Halted a Nearly Finished Final Fantasy IX Remake and Has Now Pivoted Away from Mining Its Past
Square Enix reportedly halted a nearly finished Final Fantasy IX remake and has now pivoted away from mining the franchise's back catalog.
D-FW business datebook for the week of Aug. 9
A pivotal CPI report is released Wednesday and local companies including AECOM, Brinker International and Yesway are gearing up to release earnings reports.
The job market is forcing career pivots, upskilling, reinvention
People are embracing changing careers, upskilling, and becoming their own bosses in the sluggish job market.
Colton Joseph embraces pressure as Wisconsin prepares for pivotal football season
MADISON, Wis. — A new season brings a familiar question for Wisconsin football: Can the Badgers rebound?
Microsoft’s Efforts In Making Windows 11 More Efficient Isn’t Just Due To The DRAM Shortage; Analyst Believes MacBook Neo Played A Pivotal Role In This Decision
Microsoft’s RAM optimization push for Windows 11 isn't just about DRAM costs as analyst points to Apple’s budget MacBook Neo as a major catalyst
Science on Tap: The Evolution of NEST
What does it take to prepare for the nation’s most challenging nuclear and radiological emergencies?Discover the answer with the Nuclear Emergency Support Team (NEST), the National Nuclear Security Administration’s elite emergency response unit composed of leading scientists and technical experts.Join Michael Peters, NEST Director and Deputy Director for the Office of Nuclear Incident Response, as he takes audiences on a journey through the history of nuclear response in the United States. Explore the pivotal moments that shaped NEST, learn how the organization has evolved to stay ahead of emerging threats, and gain insight into the innovative approaches that continue to strengthen national security today.Whether you're interested in science, history, technology, or emergency response, this presentation offers a unique perspective on one of the nation's most important missions.Event Details:Friday, September 4, 2026 | Doors Open at 5:30 pm | Presentation at 6:00 pmLocation: National Museum of Nuclear Science & HistoryAdmission: $12 per personRequirement: Must be 21+ to attend. An adult must accompany younger guests.
BP to sell landfill RNG business Archaea Energy
The energy major announced it’s marketing Archaea amid a strategic pivot to streamline its business. BP’s $4.1 billion acquisition of Archaea four years ago stands as a high water mark in the RNG industry.
If Not AOC, Then Who?
What do we do if Alexandria Ocasio-Cortez decides not to run for president in 2028? It makes sense that many leftists are currently focused on calling on her to take the plunge. But the absence of a Plan B, or even much discussion about one, is worrisome. The US Left can’t afford to sit out the 2028 Democratic primary. Doing so in 2024 was a disaster: our abstention self-marginalized anti-billionaire politics from the national conversation and thereby gave space for Harris to pivot to the “center” (i.e. the policy preferences of corporate donors, establishment hacks, and AIPAC). Abstaining again in 2028 would be especially counterproductive since democratic socialists now have so much wind in our sails after our big electoral wins in NYC and across the country. It’s time to deepen our momentum, organization, and profile — not to retreat to the margins during America’s single most important political battle. Even more urgently, keeping Trump’s heir out of the White House may depend on whether leftists and the party’s unprecedentedly disenchanted base can force the Democrats in 2028 to take meaningful steps towards a very angry electorate and away from the corporate-consultant blob that has helped get us into this mess. If AOC (or Abdul El-Sayed) decides to run, we should enthusiastically go all in — DSA, fighting unions, progressive organizations, anybody who wants to see a better country and world. But, as far as I can tell from the outside, there’s a real chance that she doesn’t run. And we can’t just wait and see where she lands before discussing alternatives, since AOC’s decision might not come for quite a while, giving us little time to scramble at the last minute for an alternative. So we should start working now on getting a Plan B into motion, and recruiting a good candidate for the role. Here’s one idea. A Worker Candidate — Healthcare Not Warfare 2028 Run a union worker Leftists don’t need to always run experienced, well-known socialist politicians for high-profile contests. Lula, the current president of Brazil, began his political career as a metalworker militant who ran for governor of São Paulo in 1982. Especially in an era of institutional distrust, it’s possible to lean hard into making a virtue out of a working-class comrade’s distance from traditional politics. Experience abroad shows this clearly. Rachel Kéké — an immigrant hotel housekeeper — ran as the candidate of the leftist La France Insoumise for the National Assembly in 2022, defeating a former minister in the Macron government. The Belgian Workers’ Party in 2024 won its first Flemish seat in the European Parliament by running Rudi Kennes, a three-decade veteran of the Opel Antwerp auto factory. And the South Korean left in 2024 elected auto factory militant Yoon Jong-oh to the National Assembly. If a tiny French Trotskyist organization could make such a big splash in 2002 and 2007 by running a well-spoken postal worker cadre for office — the LCR’s Olivier Besancenot received about 1.5 million first-round votes — it’s not far-fetched to expect that a much larger organization like DSA, together with a broader coalition of the willing, could run this playbook to much greater effect. This is especially the case now that almost everything DSA does immediately becomes a national news story. We don’t need someone famous. We just need a charismatic, well-vetted comrade who works in a relatable working-class occupation — e.g. a nurse, or a worker in auto or construction, or at Amazon. Ideally, they have a compelling personal story or have been part of a significant strike or organizing campaign, but even those criteria don’t necessarily have to be deal-breakers. The main lesson of the Graham Platner fiasco isn’t that we should never run outsiders for office (the momentum he generated proves the exact opposite), but that they need proper vetting and roots in democratic membership organizations like DSA or a union. In any case, there are plenty of ways to signal working-class authenticity without resorting to Platner’s or Fetterman’s performative macho white dude affect. Better to have someone of any gender or race who is actually working class, with firm socialist politics, who can speak from experience about the day-to-day realities of trying to make it in America. There are surely at least a dozen such worker leaders in our movement nationwide; we just need to sit down and convince one that their personal sacrifice for the greater good (i.e. running for president) will be worth it. If we don’t have a frontrunner with a clear path to victory like AOC (or El-Sayed, were he to win Michigan), it’s better to embrace someone whose decision to run in itself tells an important story about US politics: workers have been iced out of our political system and are now fighting hard to break back in. The novelty factor, in itself, would generate press. And it would help democratic socialists signal to the American public that our movement’s defining characteristic is that we represent workers vs. bosses, not that we’re “the furthest left” force in American politics — a framework that suggests we’re extremists and that helps our opponents isolate us from non-college-educated voters by highlighting extremely minoritarian (and misguided) stances included in DSA’s platform like prison abolition. We don’t get many opportunities to speak to tens of millions of Americans; we need to use these opportunities to broaden our appeal beyond those already in our orbit. Run to polarize the 2028 primary and general election around “Medicare for All” and “End All Aid to Israel” Why should democratic socialists use our scarce time and volunteer energy to run in a race we’re unlikely to win? Running in the 2028 primary will not only recruit us scores of members (imagine having a DSA member intervening in eleven nationally televised primary debates!), but — more importantly — it has the potential to be a decisive leap forward towards an America that finally starts meeting the needs of working people instead of HMO and AIPAC billionaire donors. Polarizing litmus tests are good, actually — as long as they’re fought for around popular demands in a thoughtful and strategic way. Democratic socialists have an opportunity and responsibility to make the 2028 primary about two of the most widely and deeply felt issues of our moment: domestically, America’s unaffordable, family-breaking private healthcare system; internationally, America’s bankrolling of the genocidal Israeli government. A candidacy relentlessly demanding Medicare for All and No Aid to Israel would pose a sharp question to the American public, the Democratic Party, and other 2028 contenders: Why can’t working-class Americans afford their healthcare bills at the same time that our government is spending at least $3.8 billion yearly to fund an Israeli regime eager to keep dragging us and the world into more forever wars? Our candidate can agitate around a clear message: I’m running to give voice to all those working-class Americans who are struggling to get by. No matter what state you live in, who you voted for in 2024, or your background, it’s just plain common sense that we should make healthcare more affordable instead of spending billions to enable the Israeli government’s crimes against humanity. Every American who agrees with me when I say ‘Medicare for All — Not a Dime for Israel’ should make their voice heard through our campaign. Racking up a high number of votes for this agenda is a crucial way to show the Democratic Party and the country as a whole that we can’t keep supporting a life-destroying status quo in our healthcare system and in the Middle East. If we want to defeat Trump’s handpicked crony this coming November, we need to speak to ordinary people’s frustrations with the status quo — we can’t keep running the same tired establishment playbook and expecting a different result. For those highly engaged voters (or skeptical media pundits) who raise concerns about wasting votes, the candidate can take the time to explain why this isn’t the case: It's true I'm a long shot. But Zohran showed anything can happen — and voting for me is a pragmatic decision, not a wasted vote. In a heavily divided primary with a large number of candidates and a very discredited establishment, my campaign and the democratic socialist movement I’m part of are positioned to be the balance of power if we can get a large enough number of voters to loudly demand Healthcare Not Warfare. Since there’s a high chance no candidate will get to 50% in the 2028 primaries, the Democrats could very well be heading towards a brokered convention, where a disciplined, principled current committed to breaking from corporate donors can play an outsized role in making sure whoever ends up with the nomination raises the banner of single-payer healthcare and cutting aid to Israel. How exactly could running this sort of primary campaign be translated into actual leverage? The candidate replies: I’m aiming to win the nomination, but if I don’t achieve that goal, my delegates and I will pledge our support in the primary only for a candidate who agrees in the general election to call for ending US aid to Israel and establishing Medicare for All at home. These are both winning planks for November against the Republicans, and the only reason I can see that other candidates haven’t yet raised these is that they’re still more scared of the donor class than they are of the people. That needs to change. If Democratic leaders want young people, workers, and those sick of the status quo to show up in big numbers this November, they need to meet us halfway. In this way, whether or not we win the nomination, democratic socialists could still play a decisive role in 2028. The approach outlined here is similar to what radical left parties periodically do in parliamentary democracies like Denmark or Sweden when they find themselves as a junior partner electorally: they dictate to center-left allies what their terms would be for enabling, from the outside, the formation of a new government. Running a Healthcare Not Warfare candidate will make it significantly more likely that the 2028 Democratic candidate stands with ordinary people instead of donors on these two pivotal planks — a shift that will, in turn, make it easier to achieve the existentially important task of defeating MAGA’s heir in November. Look at how much popular traction the Uncommitted movement got with a similar strategy in 2024 with so little on-the-ground organization — surely we can go much further with a working-class candidate, a much bigger DSA, and a Democratic Party base that has turned against Israel, billionaires, and the hacks in the party who prop them up. Objections and Responses There are quite a few objections to this proposal, many of which are very reasonable. Let me briefly address each here. Socialists shouldn’t waste their scarce time and resources on a candidate unlikely to win. This is a good rule in general, but there are important exceptions, and presidential elections are the main one. There’s no other political contest that gets anything like this level of attention and engagement in the US, so if you want to be a serious force in nationwide politics, you basically can’t afford not to have a candidate. Far from being an overall drain on our resources, running a dynamic 2028 campaign would likely result in a major net increase in members and capacity. In that spirit, the very pragmatic Milwaukee sewer socialists — who mostly ran to win at home in Wisconsin — supported Eugene Debs’s propagandistic presidential campaigns, which they correctly saw as a crucial means of recruiting to the Socialist Party. And now that the (post-1972) Democratic Party gives more weight to voters than party operatives in determining its presidential nomination, it’s become feasible to run as a socialist in primaries without risking a split in the vote against the Republicans in November. We should just support Ro Khanna, who also supports M4A and ending aid to Israel. I like Ro Khanna and would enthusiastically vote and canvass for him for president were he to get the nomination. But there’s a real chance that Khanna’s bid for office doesn’t catch on; he lacks the grassroots organizational apparatus of DSA, and, because he’s not really of the Left or labor (despite his current very good positions), he’s unlikely to generate the type of buy-in and enthusiasm that a DSA candidate would. Moreover, Khanna would be running as an individual, not as someone emerging from and building an organized movement — his campaign would not likely focus on building sustained power from below, nor would it likely polarize the 2028 primary around M4A and Israel aid. Also, and not inconsequentially, the poor electoral results for Tom Steyer and Saikat Chakrabarti this spring suggest that there’s perhaps not much of a popular appetite in the Democrats’ base to support multi-millionaire class traitors. Much better, then, to run a democratic socialist worker. If by Super Tuesday it’s clear that our campaign has captured the main left lane in the primary, Khanna should drop out and endorse us; conversely, if he’s managed to capture this lane, DSA could at that point transform its Healthcare Not Warfare campaign into an independent campaign to elect Ro Khanna focused on winning (and holding him accountable to) those two critical planks. An openness to consolidating an anti-corporate candidate by Super Tuesday is a necessary component of the strategy I’m proposing, because otherwise we risk splitting the primary votes (per DNC rules, you need at least 15% to get any delegates to convention). We should convince Shawn Fain or Sara Nelson to run for president instead. I agree it’d be great if either ran for president, but my impression is that there’s basically no chance that will happen in 2028, because both are firmly focused on their union leadership duties (and, in the case of Fain, beating back a federal witch-hunt). This plan could have DSA end up endorsing a non-socialist, non-DSAer for president. That’s against our principles. It’s a myth, and bad politics, that socialists can’t ever support candidates who aren’t members of their organization and/or who don’t call themselves socialists. Bernie, after all, was not a DSAer. And socialists abroad regularly make tactical decisions about if and when supporting a non-socialist candidate makes sense from the standpoint of promoting working-class interests, defending democracy, and building a socialist current in the process. If your “principles” prevent you and DSA from helping achieve the momentous stride forward of having a Democratic candidate in 2028 run on Medicare for All and ending aid to Israel, those “principles” are not very good. In fact, they actively undermine the causes they’re aiming to support. We shouldn’t confuse principles (working-class independence) with tactics (the best way to advance this in a given context). In my recent article in Catalyst on Milwaukee sewer socialism (I’ve uploaded the full text here), I have a section showing how similarly rigid rules about endorsements had to be eventually discarded in the old Socialist Party nationwide after WWI because they tended to lead socialists towards a sectarian abstention from broader anti-corporate electoral insurgencies beyond their party’s control. For what it’s worth, Lenin’s current under Tsarism frequently backed bourgeois candidates in the second round of elections and Lenin himself advocated that British Communists support Labour Party candidates; for his part, Kautsky in 1912 defended the German Social Democracy’s electoral pact with the Progressives in the runoffs. If our predecessors could be that tactically flexible in an era before the limits of their underlying strategic assumptions about intransigent class politics in capitalist democracies were made clear, then there’s no need to insist on being more tactically rigid today, after a century’s worth of accumulated experience. As long as you maintain your own political profile and organization while engaging in broader coalitional efforts, there’s zero inherent contradiction with the principle of political independence. More specifically: DSA and allied organizations should enthusiastically back Michigan’s Abdul El-Sayed if AOC declines to run and he throws his hat in the presidential ring. (I have no idea whether he’s even considering this path, but there’ll surely be chatter about it if he wins his Senate race this November.) Though he doesn’t call himself a socialist, El-Sayed is a principled Berniecrat, a consistent fighter for Palestine, and would have a clear path to victory. Using the “s” word is far less important than whether a campaign fights for the interests of working people at home and abroad — and whether actively participating in it can grow the organized working class and the Left. And the same holds true if a less anti-corporate candidate were, under pressure, to adopt our two Healthcare Not Warfare planks. Why focus only on M4A and ending US aid to Israel? There are so many other important issues to fight for! Obviously there are many pivotal issues beyond healthcare and Israel, and our candidate — and especially our organizations involved in the campaign — should be prepared to speak on all of these. But one of the crucial lessons of the Zohran campaign is that you have to relentlessly stay on message if you want to cut through the noise. CNN and Fox News will want to talk about DSA’s views on Venezuela and abolishing the police; we need to polarize the debate on the widely and deeply felt issues that are most favorable for growing the Left, isolating our opponents, and winning urgently needed changes. One recent poll found 63% of Americans support M4A, even after respondents were told it would raise taxes and eliminate most private insurance. Another found that 74% of Democrats opposed “providing additional economic and military support to Israel.” And focusing on two demands sets the campaign up to be able to leverage its mandate to make clear demands upon other candidates (which we can’t do if we run with a laundry list of demands). Talking about a Plan B is a distraction from the more urgent work of building a groundswell of calls on AOC to run. It’s good for DSAers, fightback unionists, and progressive organizations to try to convince AOC to run. This proposal is meant as an addendum to pushes to get AOC to run and to line DSA up for that eventuality, not as a substitute for those efforts. But I’m worried that, like in 2024, we might eventually find ourselves with no time to find a viable alternative unless we start now. DSA, with its abundant deliberative processes, moves slowly. The approach you’re suggesting seems risky. If a DSA candidate runs but doesn’t receive a lot of votes, it’ll undercut our current national momentum. This is a reasonable worry. All big initiatives always carry risks, and the path I’m advocating is certainly not free of these. That said, if a Healthcare Not Warfare campaign doesn’t catch on like we envisioned, it’s a pretty simple pivot in March 2028 to explain that in the future we really need our standard-bearers like AOC, or our growing bench of national electeds, to step up in presidential primaries. Moreover, it’s worth noting that the risk of my Plan B proposal is on the whole significantly less than the risk entailed by an AOC run. We should all back her if she runs, since she’d fire up the base, provide huge openings for organizing, have a real shot at defeating a Republican (especially given MAGA’s unpopularity), be a great standard-bearer for our issues, particularly M4A and ending aid to Israel, and be less willing than mainstream candidates to capitulate to any anti-democratic machinations from Trump and co. But it’s also true that AOC could lose, which would be a devastating setback to the country and the Left. Or she could win and find herself unable to pass much, if any, of her (and our) program, a demoralizing prospect. So if we’re willing to take these risks with AOC (and we should), it follows that we should be able to take lower-level risks if she doesn’t throw her hat in the ring. What’s Your Plan B? The US Left is facing its biggest opening for growth and influence since the 1930s. Initiatives that would have been impossible a few months ago are now potentially feasible. A President AOC is now easier to imagine, but if she ultimately assesses that the risks aren’t worth the potential reward in 2028, we can’t be left flat-footed. So even if you’re not convinced by the specifics of my Plan B, I hope you can at least agree that it’d be a disaster for us not to have one — and not to start getting a Plan B into motion. Hopefully other organizers and political currents will put forward their responses and alternative ideas ASAP. The stakes are too high to just wait and see. More As always, please share this article widely. This newsletter depends on all you lovely people to get the word out. Thank you! I uploaded the full text of my Catalyst article on Milwaukee sewer socialism here (it’s updated and 3x as long as the version published earlier on this substack). If you haven’t yet, please make sure to subscribe to Catalyst here; I read every issue front to back, highly recommend. 🌹🎵 Ivan Lins (arranged by Arthur Verocai) — “General da Banda” 🌹🎵
Black voters, divided on progressives, are pivotal in Michigan Senate primary
A disruptor or a pragmatist? In Tuesday's contest between Abdul El-Sayed and Haley Stevens, Democrats weigh whether to remake the political system or work within it.
Injunction ruling against NCAA gets pivotal update
NCAA football received a new landmark injunction ruling pertaining to eligibility for 2022 grads. But now there's clarity of the rule.
Freddy Peralta trade: Rays acquire disappointing Mets starter as they try to hang on to AL East lead
The Rays missed out on Tarik Skubal and pivoted almost immediately
Focus: Life after Orban: Hungary Inc digs in as new political era takes hold
Hungarian firms and business magnates who leveraged ties to Viktor Orban to build sprawling empires are pivoting to smaller projects as a new ruling party moves to stamp out alleged cronyism.
A Brooklyn Chef Lost His Pop-Up. Then His Business Took Off
Christopher Martin's restaurant business was thrown into crisis when he lost his location. Instead of chasing work, he focused inward and found surprising opportunities.
Ryan Gosling's family-first philosophy reshaped his Hollywood career: experts
From "Barbie" to "Ghost Rider," Ryan Gosling's pivot toward blockbuster franchises traces back to a deliberate family-first philosophy he embraced as a dad.
3 Blockbuster Trade Targets Phoenix Suns Should Monitor
As Phoenix navigates a pivotal crossroads, targeting high-impact stars like Zion Williamson and Anthony Davis could bridge the gap between developing youth and maximizing Devin Booker’s prime.